Dr. David J. Patalino, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4401 Middle Settlement Rd Ste 102, New Hartford, NY 13413 Phone: 315-735-4496 Fax: 315-798-1707 |
Mr. Aymen Rashid, Orthopaedic Surgery - Orthopaedic Surgery of the Spine Medicare: Accepting Medicare Assignments Practice Location: 1729 Burrstone Rd, New Hartford, NY 13413 Phone: 315-798-1610 Fax: 315-624-1917 |
Dr. Anthony S Lapinsky, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1729 Burrstone Rd, New Hartford, NY 13413 Phone: 315-798-1614 Fax: 315-798-1616 |
Dr. Peter A Freedman, MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 4401 Middle Settlement Rd, Suite 102, New Hartford, NY 13413 Phone: 315-735-4496 Fax: 315-735-7066 |
Andrew B Wickline, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4401 Middle Settlement Rd, Suite 201, New Hartford, NY 13413 Phone: 315-735-4496 Fax: 315-735-7066 |
James M Dennison, Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4401 Middle Settlement Rd, Suite 102, New Hartford, NY 13413 Phone: 315-735-4496 Fax: 315-735-7066 |
Jared Potts, M.D. Orthopaedic Surgery - Hand Surgery Medicare: Accepting Medicare Assignments Practice Location: 1729 Burrstone Rd, New Hartford, NY 13413 Phone: 315-798-1840 Fax: 315-624-1946 |
Dr. J Alfred Moretz Iii, M.D. Orthopaedic Surgery - Sports Medicine Medicare: Medicare Enrolled Practice Location: 1729 Burrstone Rd., New Hartford, NY 13413 Phone: 315-798-1431 Fax: 315-798-1444 |
News Archive
Coronary CT angiography (CCTA) scans allow doctors to determine safely and more quickly which patients at low-to intermediate-risk for a heart attack can be discharged from hospital emergency departments (EDs) than traditional methods, according to the results of a large, multicenter American College of Radiology Imaging Network (ACRIN) trial published online today in the New England Journal of Medicine.
Countries must set ambitious national climate commitments if they are to sustain a healthy and green recovery from the COVID-19 pandemic.
MannKind Corporation has announced that it has initiated patient enrollment in two pivotal 12-month Phase 3 clinical trials of Technosphere Insulin (TI) in patients with Type 1 and Type 2 Diabetes.
The world's first international remote training session utilizing advanced 3D sinus models and a telemedicine system has taken place, highlighting a new mode of medical training in the Covid-19 era.
› Verified 3 days ago